| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0003 |